Long-Term Debt: The sum of all long term debt fields.
Perspective Therapeutics, Inc. (CATX) had Long-Term Debt of $1.57M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.88M |
|
$-103.12M |
|
-- |
|
$0.88M |
|
$114.45M |
|
$-113.56M |
|
$9.14M |
|
$-104.43M |
|
$-104.43M |
|
$-104.43M |
|
$-104.43M |
|
$-103.12M |
|
$-104.43M |
|
$-113.56M |
|
$-113.04M |
|
73.81M |
|
73.81M |
|
$-1.40 |
|
$-1.40 |
|
| Balance Sheet Financials | |
$148.39M |
|
$76.60M |
|
$118.58M |
|
$266.97M |
|
$28.68M |
|
|
Long-Term Debt |
$1.57M |
$31.26M |
|
$59.94M |
|
$207.03M |
|
$167.03M |
|
$207.03M |
|
74.34M |
|
| Cash Flow Statement Financials | |
$-82.48M |
|
$41.23M |
|
$10.30M |
|
$61.58M |
|
$30.63M |
|
$-30.95M |
|
$8.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.17 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
100.00% |
|
-12846.61% |
|
-12846.61% |
|
-12786.88% |
|
-11813.12% |
|
-11665.27% |
|
$-95.23M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
147.33 |
|
2.48 |
|
-50.44% |
|
-62.52% |
|
-39.12% |
|
-50.06% |
|
$2.79 |
|
$-1.29 |
|
$-1.12 |
|